# Study of Atezolizumab in Advanced Non-oncogene-addicted NSCLC With PD-L1 ≥50%, Including Longitudinal c-FLIP Assessment in Monocytic MDSCs.

> **NCT07051928** · — · NOT_YET_RECRUITING · sponsor: **Fondazione Policlinico Universitario Agostino Gemelli IRCCS** · enrollment: 107 (estimated)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

- **DIAGNOSTIC_TEST:** c-FLIP expression on MDSC

## Key facts

- **NCT ID:** NCT07051928
- **Lead sponsor:** Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-07
- **Primary completion:** 2027-07
- **Final completion:** 2029-07
- **Target enrollment:** 107 (ESTIMATED)
- **Last updated:** 2025-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07051928

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07051928, "Study of Atezolizumab in Advanced Non-oncogene-addicted NSCLC With PD-L1 ≥50%, Including Longitudinal c-FLIP Assessment in Monocytic MDSCs.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07051928. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*